Development of a core outcome set for basal cell carcinoma

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Daniel I. Schlessinger - , Northwestern University, Washington University St. Louis (Autor:in)
  • Kelly A. Reynolds - , Northwestern University, University of Cincinnati (Autor:in)
  • McKenzie A. Dirr - , Northwestern University (Autor:in)
  • Sarah A. Ibrahim - , Northwestern University (Autor:in)
  • Arianna F. Yanes - , University of Pennsylvania (Autor:in)
  • Jake M. Lazaroff - , Northwestern University (Autor:in)
  • Victoria Godinez-Puig - , Northwestern University (Autor:in)
  • Brian R. Chen - , Northwestern University (Autor:in)
  • Anastasia O. Kurta - , Saint Louis University (Autor:in)
  • Jill K. Cotseones - , Northwestern Medicine Regional Medical Group (Autor:in)
  • Sarah G. Chiren - , Northwestern University (Autor:in)
  • Karina C. Furlan - , Rush University (Autor:in)
  • Sanjana Iyengar - , West Virginia University (Autor:in)
  • Ramona Behshad - , Saint Louis University (Autor:in)
  • Danielle M. DeHoratius - , University of Pennsylvania (Autor:in)
  • Pablo Denes - , Northwestern University (Autor:in)
  • Aaron M. Drucker - , University of Toronto (Autor:in)
  • Leonard M. Dzubow - (Autor:in)
  • Jeremy R. Etzkorn - , University of Pennsylvania (Autor:in)
  • Catherine A. Harwood - , Barts Health NHS Trust, Queen Mary University of London (Autor:in)
  • John Y.S. Kim - , Northwestern University (Autor:in)
  • Naomi Lawrence - , Rowan University (Autor:in)
  • Erica H. Lee - , Memorial Sloan-Kettering Cancer Center (Autor:in)
  • Gary S. Lissner - , Northwestern University (Autor:in)
  • Ashfaq A. Marghoob - , Memorial Sloan-Kettering Cancer Center (Autor:in)
  • Rubeta N. Matin - , Churchill Hospital (Autor:in)
  • Adam R. Mattox - , University of Minnesota System (Autor:in)
  • Bharat B. Mittal - , Northwestern University (Autor:in)
  • J. Regan Thomas - , Northwestern University (Autor:in)
  • Xiaolong Alan Zhou - , Northwestern University (Autor:in)
  • David Zloty - , University of British Columbia (Autor:in)
  • Jochen Schmitt - , Zentrum für evidenzbasierte Gesundheitsversorgung (Autor:in)
  • Jamie J. Kirkham - , University of Manchester (Autor:in)
  • April W. Armstrong - , University of Southern California (Autor:in)
  • Nicole Basset-Seguin - , Université Paris Cité (Autor:in)
  • Elizabeth M. Billingsley - , Pennsylvania State University (Autor:in)
  • Jeremy S. Bordeaux - , Case Western Reserve University (Autor:in)
  • Jerry Brewer - , Mayo Clinic Rochester, MN (Autor:in)
  • Marc Brown - , University of Rochester (Autor:in)
  • Mariah Brown - , University of Colorado Denver (Autor:in)
  • Scott A.B. Collins - , Dermatology Associates (Autor:in)
  • Maria Concetta Fargnoli - , University of L'Aquila (Autor:in)
  • Sergio Jobim De Azevedo - , Universidade Federal do Rio Grande do Sul (Autor:in)
  • Reinhard Dummer - , University of Zurich (Autor:in)
  • Alexander Eggermont - , Utrecht University (Autor:in)
  • Glenn D. Goldman - , University of Vermont (Autor:in)
  • Merete Haedersdal - , Universität Kopenhagen (Autor:in)
  • Elizabeth K. Hale - , New York University (Autor:in)
  • Allison Hanlon - , Vanderbilt University (Autor:in)
  • Kelly L. Harms - , University of Michigan, Ann Arbor (Autor:in)
  • Conway C. Huang - , University of Alabama at Birmingham (Autor:in)
  • Eva A. Hurst - , Distinctive Dermatology (Autor:in)
  • Gino K. In - , University of Southern California (Autor:in)
  • Nicole Kelleners-Smeets - , Maastricht University (Autor:in)
  • Meenal Kheterpal - , Duke University (Autor:in)
  • Barry Leshin - , Vivantes Clinic Berlin (Autor:in)
  • Michel Mcdonald - , Vanderbilt University (Autor:in)
  • Stanley J. Miller - , Johns Hopkins University (Autor:in)
  • Alexander Miller - , University of California at Irvine (Autor:in)
  • Eliot N. Mostow - , Northeastern Ohio Universities College of Medicine (Autor:in)
  • Myrto Trakatelli - , Aristotle University of Thessaloniki (Autor:in)
  • Kishwer S. Nehal - , Memorial Sloan-Kettering Cancer Center (Autor:in)
  • Desiree Ratner - , New York University (Autor:in)
  • Howard Rogers - , Advanced Dermatology (Autor:in)
  • Kavita Y. Sarin - , Stanford University (Autor:in)
  • Seaver L. Soon - , The Skin Clinic MD (Autor:in)
  • Thomas Stasko - , University of Oklahoma (Autor:in)
  • Paul A. Storrs - , University of Illinois at Chicago (Autor:in)
  • Luca Tagliaferri - , Catholic University of the Sacred Heart (Autor:in)
  • Allison T. Vidimos - , Cleveland Clinic Foundation (Autor:in)
  • Sandra L. Wong - , Dartmouth Health (Autor:in)
  • Siegrid S. Yu - , University of California at San Francisco (Autor:in)
  • Iris Zalaudek - , Università degli Studi di Trieste (Autor:in)
  • Nathalie C. Zeitouni - , Medical Dermatology Specialists (Autor:in)
  • John A. Zitelli - , University of Pittsburgh (Autor:in)
  • Emily Poon - , Northwestern University (Autor:in)
  • Joseph F. Sobanko - , University of Pennsylvania (Autor:in)
  • Todd V. Cartee - , Pennsylvania State University (Autor:in)
  • Ian A. Maher - , University of Minnesota System (Autor:in)
  • Murad Alam - , Northwestern University (Autor:in)

Abstract

Background: There is variation in the outcomes reported in clinical studies of basal cell carcinoma. This can prevent effective meta-analyses from answering important clinical questions. Objective: To identify a recommended minimum set of core outcomes for basal cell carcinoma clinical trials. Methods: Patient and professional Delphi process to cull a long list, culminating in a consensus meeting. To be provisionally accepted, outcomes needed to be deemed important (score, 7-9, with 9 being the maximum) by 70% of each stakeholder group. Results: Two hundred thirty-five candidate outcomes identified via a systematic literature review and survey of key stakeholders were reduced to 74 that were rated by 100 health care professionals and patients in 2 Delphi rounds. Twenty-seven outcomes were provisionally accepted. The final core set of 5 agreed-upon outcomes after the consensus meeting included complete response; persistent or serious adverse events; recurrence-free survival; quality of life; and patient satisfaction, including cosmetic outcome. Limitations: English-speaking patients and professionals rated outcomes extracted from English language studies. Conclusion: A core outcome set for basal cell carcinoma has been developed. The use of relevant measures may improve the utility of clinical research and the quality of therapeutic guidance available to clinicians.

Details

OriginalspracheEnglisch
Seiten (von - bis)573-581
Seitenumfang9
FachzeitschriftJournal of the American Academy of Dermatology
Jahrgang87
Ausgabenummer3
PublikationsstatusVeröffentlicht - Sept. 2022
Peer-Review-StatusJa

Externe IDs

PubMed 35551965

Schlagworte

Ziele für nachhaltige Entwicklung

ASJC Scopus Sachgebiete

Schlagwörter

  • basal cell carcinoma, core, measure, outcome, set, skin cancer